Department of Pulmonary Medicine, All India Institute of Medical Sciences, Jodhpur.
Department of Pathology, All India Institute of Medical Sciences, Jodhpur .
Monaldi Arch Chest Dis. 2020 Jul 30;90(3). doi: 10.4081/monaldi.2020.1462.
Biphasic pulmonary blastoma (BPB) is an extremely rare highly aggressive malignant tumor that arises from fetal lung tissue and has the classical biphasic histology of epithelial and mesenchymal components. It is usually seen in adults with a slight male predominance and smokers. Previously grouped along with well-differentiated fetal adenocarcinoma (WDFA), and pleuropulmonary blastoma (PPB), now it is considered a separate variant and grouped under sarcomatoid neoplasms. Symptoms include chest pain, cough, hemoptysis and it is asymptomatic in at least one-third of the cases. A biopsy is essential for diagnosis and surgical excision is the treatment of choice. Prognosis is poor with 5-year survival less than 20% and recurrence occurring within 12 months of surgery. An aggressive multimodality approach is required for its management and active follow up surveillance is needed to look for recurrence.
肺胚细胞瘤(BPB)是一种非常罕见的高度侵袭性恶性肿瘤,起源于胎儿肺组织,具有上皮和间叶成分的经典双相组织学特征。它通常发生在有轻微男性优势和吸烟者的成年人中。以前与分化良好的胎儿腺癌(WDFA)和胸膜肺母细胞瘤(PPB)一起归类,现在被认为是一种单独的变异体,并归类为肉瘤样肿瘤。症状包括胸痛、咳嗽、咯血,至少有三分之一的病例为无症状。活检是诊断的必要手段,手术切除是首选治疗方法。预后较差,5 年生存率低于 20%,术后 12 个月内复发。需要采用积极的多模式方法进行治疗,并需要积极的随访监测以寻找复发。